In summary, we demonstrated that CPCGI effectively inhibited NLRP3 inflammasome activation‐mediated pyroptosis in microglia, both in vitro and in vivo, thereby improving the neuroinflammatory microenvironment and promoting neurological recovery following traumatic brain injury. The gene discussed is NLRP3; the disease is injury.